We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$777M
AUM Growth
+$334M
Cap. Flow
+$396M
Cap. Flow %
50.94%
Top 10 Hldgs %
6.27%
Holding
1,320
New
618
Increased
231
Reduced
124
Closed
347

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$7M
2
CLF icon
Cleveland-Cliffs
CLF
+$6.43M
3
TPG icon
TPG
TPG
+$5.71M
4
F icon
Ford
F
+$5.07M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.99M

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$2.55M
2
HON icon
Honeywell
HON
+$2.51M
3
LEN icon
Lennar Class A
LEN
+$2.39M
4
AVGO icon
Broadcom
AVGO
+$2.24M
5
EOG icon
EOG Resources
EOG
+$2.17M

Sector Composition

Rank Sector Weight
1 Financials 17.64%
2 Technology 17.26%
3 Industrials 13.44%
4 Healthcare 12.8%
5 Consumer Discretionary 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATMU icon
501
Atmus Filtration Technologies
ATMU
$4.18B
$387K 0.05%
6,825
+2,093
+44% +$124K
SEIC icon
502
SEI Investments
SEIC
$11.7B
$386K 0.05%
4,916
-5,200
-51% -$428K
EXPO icon
503
Exponent
EXPO
$2.94B
$385K 0.05%
+5,902
New +$419K
KIM icon
504
Kimco Realty
KIM
$17.6B
$385K 0.05%
+17,138
New +$378K
PEG icon
505
Public Service Enterprise Group
PEG
$38.8B
$385K 0.05%
4,754
-5,481
-54% -$449K
FTI icon
506
TechnipFMC
FTI
$29.8B
$385K 0.05%
+5,562
New +$334K
STGW icon
507
Stagwell
STGW
$1.84B
$382K 0.05%
+60,752
New +$340K
PKX icon
508
POSCO
PKX
$15.3B
$382K 0.05%
+6,524
New +$396K
GPCR icon
509
Structure Therapeutics
GPCR
$3.34B
$382K 0.05%
+7,916
New +$542K
ARQT icon
510
Arcutis Biotherapeutics
ARQT
$3.44B
$381K 0.05%
+16,181
New +$413K
BLTE
511
Belite Bio
BLTE
$6.13B
$378K 0.05%
+2,372
New +$399K
USAR
512
USA Rare Earth Inc
USAR
$3.87B
$378K 0.05%
+24,962
New +$484K
CHDN icon
513
Churchill Downs
CHDN
$5.81B
$378K 0.05%
+4,205
New +$399K
ASAN icon
514
Asana
ASAN
$1.7B
$376K 0.05%
58,698
+30,082
+105% +$265K
TJX icon
515
TJX Companies
TJX
$171B
$376K 0.05%
+2,352
New +$366K
OCS icon
516
Oculis Holding
OCS
$708M
$375K 0.05%
+14,118
New +$374K
VMC icon
517
Vulcan Materials
VMC
$36.4B
$371K 0.05%
+1,364
New +$401K
BCRX icon
518
BioCryst Pharmaceuticals
BCRX
$2.39B
$371K 0.05%
+38,952
New +$302K
CORZ icon
519
Core Scientific
CORZ
$7.63B
$371K 0.05%
+24,769
New +$422K
AEO icon
520
American Eagle Outfitters
AEO
$2.91B
$369K 0.05%
22,094
-8,034
-27% -$180K
PBA icon
521
Pembina Pipeline
PBA
$29.3B
$368K 0.05%
+8,221
New +$349K
CRDO icon
522
Credo Technology Group
CRDO
$41.7B
$367K 0.05%
+3,911
New +$476K
RPM icon
523
RPM International
RPM
$13B
$367K 0.05%
3,693
-8,108
-69% -$876K
SBS icon
524
Sabesp
SBS
$19.9B
$366K 0.05%
+59,900
New +$329K
DASH icon
525
DoorDash
DASH
$81.9B
$364K 0.05%
2,425
-2,264
-48% -$418K

Similar funds

AXQ Capital's Q1 2026 Portfolio in Review

As of Q1 2026, AXQ Capital held 1,320 positions worth $777M, up 75% from $443M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

AXQ Capital deployed $396M of net new capital in Q1 2026, opening 618 new positions and adding to 231 existing holdings. Its largest new stake was TPG: 111,339 shares worth $4.51M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Stryker, an estimated $2.04M trimmed.

  • AXQ Capital's largest Q1 2026 buy was TPG: 111,339 shares worth $4.51M.
  • AXQ Capital added most to Boston Scientific in Q1 2026, an estimated $7M increase.
  • AXQ Capital's biggest Q1 2026 reduction was Stryker, cutting an estimated $2.04M.
  • AXQ Capital fully exited Marsh in Q1 2026, selling an estimated $2.55M.
  • AXQ Capital's ten largest holdings make up 6.3% of its $777M portfolio in Q1 2026.
  • AXQ Capital opened 618 new positions and closed 347 in Q1 2026.
  • AXQ Capital's portfolio value rose 75% quarter-over-quarter to $777M.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.